Clinical Trial Update: Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the modified BFM-95 regimen as first-line chemotherapy in adults with T-lymphoblastic lymphoma is ongoing or not yet reporte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• T-lymphoblastic Lymphoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lymphoma, Lymphoblastic | Phase 2 | Status: UNKNOWN